[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

3 clusters · 6 sources · 16 days · First seen · Last updated

US generic drug price-fixing settlement

Overview

A multistate coalition of 45 states and territories is seeking court approval for additional settlements with generic drug manufacturers to resolve allegations of a widespread conspiracy to manipulate prices and reduce competition.

Recent developments include agreements with Ascend Laboratories, Mayne Pharma, and Citron Pharma. Ascend and Mayne are expected to pay a combined $1.05 million to the states. The settlement with Citron Pharma is non-monetary, as the company has ceased operations. These new agreements include injunctive terms and internal reforms designed to ensure future antitrust compliance.

These developments follow previous settlements with companies such as Glenmark, Lannett, Bausch, Apotex, Heritage, Emcure, and Sandoz, which totaled $496.5 million. The coalition is also seeking a $400 million settlement involving Sandoz.

Consumers in the United States who purchased eligible generic medications—including treatments for cancer, diabetes, ADHD, and various topical conditions—between May 2009 and December 2019 may be entitled to compensation. To facilitate the process, forty-eight Attorneys General established a composite website for potential claimants to verify information and report claims. While many residents are eligible, specific restrictions apply to residents of Louisiana regarding settlement payments. The deadline for submitting claims is March 8, 2027.

Entities

Glenmark · Sandoz · Lannett · Ascend Laboratories · California Department of Justice

Timeline

  1. [BUSINESS] 2 sources
    States seek court approval for generic drug manufacturer settlements

    A coalition of 45 states and territories is seeking court approval for settlements with several generic drug manufacturers to resolve allegations of price-fixing and antitrust conspiracies.

  2. [BUSINESS] 2 sources
    Generic drug settlement offers compensation for price-fixing allegations

    Pharmaceutical companies including Sandoz and Glenmark have agreed to a massive settlement following allegations of generic drug price fixing affecting consumers in the US.

  3. [BUSINESS] 2 sources
    California Attorney General urges consumer claims in generic drug settlement

    California Attorney General Rob Bonta urges consumers to claim compensation from a $96.5 million settlement involving generic drug manufacturers accused of price-fixing between 2009 and 2019.

Sources

1079ishot.com · healthnewsillinois.com · independent.com · kpel965.com · news.delaware.gov · wgmd.com

This summary has been updated 1 time: see revision history